BRNS vs CMCSA · $38.2M cap vs P/E 8.6, rev $61.40B
Barinthus Biotherapeutics plc (BRNS) versus Comcast Corp (CMCSA) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Comcast Corp (CMCSA) is a telecom services company listed on US. It is led by Brian Roberts.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported CMCSA revenue for 2026-06-30 was $61.40B. Net income was $5.70B. Revenue was up 95.2% from 2026-03-31 to 2026-06-30. CMCSA currently screens at market cap $130.64B and trailing P/E 8.6.
BRNS currently screens at market cap $38.2M. CMCSA currently screens at market cap $130.64B and trailing P/E 8.6.
Not investment advice. Open the BRNS and CMCSA stock pages for the full models.
Not investment advice.